Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × belotecan × Clear all

NCT00430144 2012-04-26

Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix

Phase 2 Completed

Uterine Cervical Neoplasms